Literature DB >> 6542070

Purification of dermonecrotic toxin from a sonic extract of Pasteurella multocida SP-72 serotype D.

T Nakai, A Sawata, M Tsuji, Y Samejima, K Kume.   

Abstract

A procedure was developed to purify dermonecrotic toxin (DNT) from a sonic extract of a serotype D strain of Pasteurella multocida. Sonic extract containing DNT was applied to a DEAE-Sephacel column and eluted by a linear gradient of NaCl. Upon rechromatographing, fractions with dermonecrotic activity for guinea pigs were applied on a second Sephacel column, and a pooled fraction with the toxic activity was filtered through a Sephadex G-200 column. Pooled fractions with the toxic activity were subjected to polyacrylamide disc gel electrophoresis (PAGE), and the toxic substance was eluted from each sliced gel. Eluted fractions with the toxic activity were rechromatographed on a second Sephadex G-200 column, and a pooled fraction with high dermonecrotic activity was referred to as a purified DNT. The activity of purified DNT was increased by 1,000 times, and the average yield was about 1.8%. The purified DNT was homogeneous as determined by Ouchterlony double immunodiffusion, crossed immunoelectrophoresis, and thin-layer isoelectric focusing in polyacrylamide gels and gave a single band on PAGE and sodium dodecyl sulfate-PAGE. The molecular weight of the toxin was ca. 160,000 as determined by sodium dodecyl sulfate-PAGE. The isoelectric point of the toxin was ca. 4.7 to 4.8. Amino acid analysis of the purified DNT revealed that the toxin was composed of characteristically high proportions of glutamic acid, aspartic acid, glycine, proline, alanine, and leucine. The minimal necrotizing dose of the toxin was about 1 ng of protein, and the 50% lethal dose per mouse was 0.2 micrograms. The purified DNT was heat labile and sensitive to inactivation by trypsin, Formalin, and glutaraldehyde.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542070      PMCID: PMC261550          DOI: 10.1128/iai.46.2.429-434.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Intracellular localization of the dermonecrotic toxin of Bordetella pertussis.

Authors:  J L Cowell; E L Hewlett; C R Manclark
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

2.  Lienotoxicity of Bordetella pertussis in mice.

Authors:  T Iida; T Okonogi
Journal:  J Med Microbiol       Date:  1971-02       Impact factor: 2.472

3.  Heat-labile toxin of Bordetella pertussis purified by preparative acrylamide gel electrophoresis.

Authors:  Y Nakase; K Takatsu; M Tateishi; K Sekiya; T Kasuga
Journal:  Jpn J Microbiol       Date:  1969-12

4.  Production of lesions similar to naturally occurring swine atrophic rhinitis by cell-free sonicated extract of Bordetella bronchiseptica.

Authors:  M Hanada; K Shimoda; S Tomita; Y Nakase; Y Nishiyama
Journal:  Nihon Juigaku Zasshi       Date:  1979-02

5.  Pathology of experimental atrophic rhinitis in swine infected with Alcaligenes bronchisepticus or Pasteurella multocida.

Authors:  M Nakagawa; T Shimizu; Y Motoi
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1974

6.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

Authors:  K Weber; J R Pringle; M Osborn
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

7.  Atrophic rhinitis produced by intranasal inoculation of Bordetella bronchiseptica in hysterectomy produced colostrum-deprived pigs.

Authors:  T Shimizu; M Nakagawa; S Shibata; K Suzuki
Journal:  Cornell Vet       Date:  1971-10

8.  Nasal infection of Alcaligenes bronchisepticus (Bordetella bronchiseptica) and lesions in newborn rabbits.

Authors:  M Maeda; T Shimizu
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1975

9.  Adherence of Bordetella bronchiseptica to swine nasal epithelial cells and its possible role in virulence.

Authors:  Y Yokomizo; T Shimizu
Journal:  Res Vet Sci       Date:  1979-07       Impact factor: 2.534

10.  Experimental atrophic rhinitis in gnotobiotic pigs.

Authors:  O P Miniats; J A Johnson
Journal:  Can J Comp Med       Date:  1980-10
View more
  23 in total

1.  Association of Pasteurella multocida toxin with vimentin.

Authors:  Hiroaki Shime; Takahiro Ohnishi; Kaori Nagao; Kiyomasa Oka; Toshifumi Takao; Yasuhiko Horiguchi
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Effect of Pasteurella multocida toxin on bone resorption in vitro.

Authors:  R Felix; H Fleisch; P L Frandsen
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

3.  Crystallization and preliminary crystallographic studies of the Pasteurella multocida toxin catalytic domain.

Authors:  Masayuki Miyazawa; Kengo Kitadokoro; Shigeki Kamitani; Hiroaki Shime; Yasuhiko Horiguchi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-18

4.  Pasteurella multocida toxin is a potent inducer of anchorage-independent cell growth.

Authors:  T E Higgins; A C Murphy; J M Staddon; A J Lax; E Rozengurt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  The characterization of ion channels formed by Pasteurella multocida dermonecrotic toxin.

Authors:  O V Krasilnikov; V I Ternovsky; D G Navasardyants; L I Kalmykova
Journal:  Med Microbiol Immunol       Date:  1994-11       Impact factor: 3.402

6.  Stimulation of osteoclast-like cell formation by Pasteurella multocida toxin from hemopoietic progenitor cells in mouse bone marrow cultures.

Authors:  I Jutras; B Martineau-Doizé
Journal:  Can J Vet Res       Date:  1996-01       Impact factor: 1.310

7.  Pasteurella multocida toxin: potent mitogen for cultured fibroblasts.

Authors:  E Rozengurt; T Higgins; N Chanter; A J Lax; J M Staddon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

8.  Adherence of Pasteurella multocida or Bordetella bronchiseptica to the swine nasal epithelial cell in vitro.

Authors:  T Nakai; K Kume; H Yoshikawa; T Oyamada; T Yoshikawa
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

9.  Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxin-containing conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida.

Authors:  T G Kimman; C W Löwik; L J van de Wee-Pals; C W Thesingh; P Defize; E M Kamp; O L Bijvoet
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

Review 10.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.